Variant report
Variant | nsv979008 |
---|---|
Chromosome Location | chr2:62757678-62762052 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:6)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:6 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr2:62761320-62761470 | AG10803 | skin: | n/a | n/a |
2 | E2F4 | chr2:62757738-62757854 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | E2F6 | chr2:62758186-62758618 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | POLR2A | chr2:62761200-62761342 | K562 | blood: | n/a | n/a |
5 | TCF7L2 | chr2:62757099-62757718 | HepG2 | liver: | n/a | chr2:62757382-62757392 chr2:62757381-62757395 chr2:62757384-62757393 chr2:62757380-62757396 chr2:62757380-62757396 chr2:62757383-62757392 |
6 | TCF7L2 | chr2:62757021-62757701 | HEK293 | kidney: | n/a | chr2:62757382-62757392 chr2:62757381-62757395 chr2:62757384-62757393 chr2:62757380-62757396 chr2:62757380-62757396 chr2:62757383-62757392 |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:62750475..62752947-chr2:62754435..62758816,4 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000229503 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4494727 | chr2:62757683-62757684 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs552147073 | chr2:62757699-62757700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs141490663 | chr2:62757707-62757708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs538154484 | chr2:62757722-62757723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs550022868 | chr2:62757774-62757775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549433745 | chr2:62757775-62757776 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs569384007 | chr2:62757789-62757790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs17025438 | chr2:62757790-62757791 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs549696359 | chr2:62757828-62757829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs150850945 | chr2:62757877-62757878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs190821629 | chr2:62757898-62757899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539485809 | chr2:62757937-62757938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs139282855 | chr2:62757948-62757949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs4490165 | chr2:62757985-62757986 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs543756623 | chr2:62757991-62757992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs561989270 | chr2:62757994-62757995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs4399711 | chr2:62758044-62758045 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs181694602 | chr2:62758054-62758055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs149300921 | chr2:62758065-62758066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs527785578 | chr2:62758084-62758085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575190680 | chr2:62758085-62758086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs552208536 | chr2:62758088-62758089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564151456 | chr2:62758089-62758090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs185109225 | chr2:62758101-62758102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550086573 | chr2:62758117-62758118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs6708322 | chr2:62758232-62758233 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs17575420 | chr2:62758283-62758284 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs547966773 | chr2:62758292-62758293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs566093875 | chr2:62758312-62758313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539546693 | chr2:62758335-62758336 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs542780054 | chr2:62758372-62758373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs146232910 | chr2:62758426-62758427 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs537022747 | chr2:62758450-62758451 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs139434449 | chr2:62758457-62758458 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs369037299 | chr2:62758558-62758559 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs573870690 | chr2:62758596-62758597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs540917636 | chr2:62758611-62758612 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs6752833 | chr2:62758620-62758621 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs577378594 | chr2:62758646-62758647 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs545910073 | chr2:62758658-62758659 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs144138769 | chr2:62758754-62758755 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs6708968 | chr2:62758756-62758757 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs140781388 | chr2:62758795-62758796 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs527620527 | chr2:62758865-62758866 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs562288670 | chr2:62758918-62758919 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs529594562 | chr2:62758919-62758920 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs146433913 | chr2:62758922-62758923 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs6753189 | chr2:62758933-62758934 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs533539075 | chr2:62758964-62758965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs551530391 | chr2:62759024-62759025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:62749200-62760400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr2:62754200-62758400 | Weak transcription | Pancreas | Pancrea |
3 | chr2:62754200-62766800 | Weak transcription | Ovary | ovary |
4 | chr2:62758400-62759000 | Enhancers | Pancreas | Pancrea |
5 | chr2:62759000-62766600 | Weak transcription | Pancreas | Pancrea |
6 | chr2:62760400-62760800 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |